Related by context. All words. (Click for frequent words.) 69 Mipomersen 68 Dasatinib 68 liposomal formulation 68 MEK inhibitor 68 Dapagliflozin 67 intravenously administered 67 metaglidasen 67 selective modulator 67 protein tyrosine phosphatase 1B 67 orally bioavailable 67 nucleoside analog 67 Sapacitabine 67 Sym# 66 IAP inhibitor 66 OMP #M# 66 HCV protease 66 Pertuzumab 66 teriflunomide 66 CCX# 66 ZD# [001] 65 radezolid 65 Lisofylline 65 HuLuc# 65 PRT# 65 cilengitide 65 Tyrima 65 PDE4 inhibitor 65 VA# [002] 65 CBLC# 65 angiogenesis inhibitor 65 proteasome inhibitor 65 PEG SN# 65 systemically administered 65 Nanobody ® 65 5 HT4 65 YONDELIS 65 Nanobody 65 proteasome inhibitors 65 Factor VIIa 65 receptor tyrosine kinase inhibitor 65 GW# [003] 65 AEG# 65 CYT# potent vascular disrupting 65 JAK2 inhibitor 65 protein kinase inhibitor 65 SCH # 65 cediranib 65 MYDICAR ® 65 oral prodrug 65 orally dosed 65 administered subcutaneously 65 preclinically 65 HuMax EGFr 64 reslizumab 64 PD LID 64 DNA intercalator 64 Gleevec resistant 64 DU #b 64 neuroprotectant 64 immunotherapeutic agent 64 SRT# [003] 64 flavopiridol 64 Litx 64 ZOLINZA 64 vinca alkaloid 64 CCR9 antagonist 64 ospemifene 64 huC# DM4 64 PEGylated anti 64 sodium glucose cotransporter 64 HCV protease inhibitor 64 cannabinor 64 Posiphen 64 integrase inhibitor 64 CR# vcMMAE 64 TNF Tumor Necrosis Factor 64 PSMA ADC 64 gefitinib Iressa 64 Interferon alpha 64 selective agonist 64 dasatinib Sprycel 64 humanized antibody 64 Blinatumomab 64 ELACYT 64 histone deacetylase inhibitor 64 ESBA# 64 CDK inhibitor 64 insulin sensitizers 64 generation purine nucleoside 64 siRNA therapeutic 64 multi kinase inhibitor 64 ISIS # 64 renin inhibitors 64 GLPG# 64 orally administered inhibitor 64 GPIIb IIIa 64 HCV protease inhibitors 64 INT# [002] 64 BiTE 64 CG# [003] 64 vascular disrupting agent 64 Enzastaurin 64 Elvitegravir 64 mertansine 64 GFT# 63 DCCR 63 PSN# [001] 63 Hedgehog inhibitor 63 Ataluren 63 inhibitor RG# 63 evaluating tivozanib 63 investigational humanized monoclonal antibody 63 Safinamide 63 HuMax CD# 63 PARP inhibitors 63 generation antisense inhibitor 63 HQK 63 Tocilizumab 63 DXL# 63 ImmunoVEX HSV2 63 PSN# [002] 63 XmAb# 63 immunotoxin 63 factor Xa 63 RLY# 63 BAY #-# 63 dexpramipexole 63 LY# [003] 63 adenosine receptor 63 Elesclomol 63 Degarelix 63 sd rxRNA 63 metreleptin 63 Trandolapril 63 PTP 1B 63 Methylnaltrexone 63 Fc fusion protein 63 Locked Nucleic Acid LNA 63 selective antagonist 63 castrate resistant prostate cancer 63 stable nucleic acid 63 Linagliptin 63 Aurora kinase inhibitor 63 Azedra 63 Vandetanib 63 radiolabeled 63 CEQ# 63 CRLX# 63 canakinumab 63 chemokine receptor 63 pertuzumab 63 highly selective inhibitor 63 TBC# 63 PEGylated interferon 63 IAP inhibitors 63 enkephalin 63 eprotirome 63 uricase 63 antibody MAb 63 ThGRF 63 Cethromycin 63 tyrosine kinase inhibitor 63 antisense inhibitors 63 pharmacodynamic properties 63 mGluR2 NAM 63 SERMs 63 hedgehog pathway 63 selective estrogen receptor modulator 63 GRN# 63 KB# [002] 63 intranasal formulation 63 polymerase inhibitor 63 R#/MEM # 63 corticosteroid dexamethasone 63 Boceprevir 63 Phase Ib study 63 Crizotinib 63 anticancer compound 63 Affibody 63 Phase 1a clinical 63 PCK# 63 GLYX 63 inhaled formulation 63 Lovastatin 63 Dalbavancin 63 SGLT2 inhibitors 63 mda 7 63 receptor blocker 63 partial agonist 62 ApoB SNALP 62 chimeric monoclonal antibody 62 Liposomal 62 immune modulating 62 sorafenib tablets 62 riociguat 62 Zoraxel 62 humanised antibody 62 BRAF inhibitor 62 nucleotide analogue 62 novel peptide 62 INCB# [001] 62 otelixizumab 62 NEUGENE 62 gamma secretase inhibitor 62 resolvins 62 histone deacetylase inhibitors 62 AAG geldanamycin analog 62 pan HDAC inhibitor 62 Diamyd R 62 alagebrium 62 highly selective endothelin 62 HCV NS5B polymerase 62 oral rivaroxaban 62 thyroid hormone receptor 62 CRTH2 62 Tarvacin 62 Afatinib 62 ALN TTR 62 canagliflozin 62 Hsp# Inhibitor 62 sorafenib Nexavar 62 selective inhibitor 62 VitiGam 62 volociximab 62 phase IIa clinical 62 oral renin inhibitor 62 5alpha reductase 62 AMN# [001] 62 aleglitazar 62 PPARγ 62 Temsirolimus 62 CDP# 62 Kinase Inhibitor 62 HGS# 62 IMA# 62 Golimumab 62 Fingolimod 62 beta 1a 62 therapeutic monoclonal antibody 62 PKC# 62 Guanilib 62 lumiliximab 62 Genz # 62 insulin sensitizer 62 Preclinical studies suggest 62 secretory phospholipase A2 sPLA2 62 Angiocept 62 edifoligide 62 FVIIa 62 CCR5 antagonist 62 EndoTAG TM -1 62 SGLT2 62 BCR ABL inhibitor 62 humanized anti 62 OncoVEX GM CSF 62 Carfilzomib 62 SAR# [002] 62 selective inhibition 62 non nucleoside inhibitor 62 anticancer agent 62 VAPRISOL 62 HGS ETR2 62 ProSavin 62 Aurora Kinase 62 PI3K inhibitor 62 fosbretabulin 62 anionic backbone 62 potent anticancer 62 Symadex 62 Protein Kinase C 62 CTAP# Capsules 62 PEGylated Fab fragment 62 SAR# [004] 62 factor Xa inhibitor 62 targeted radiotherapeutic 62 Cetrorelix 62 Kahalalide F 62 LY# [002] 62 DAPT 62 ENMD # 62 Silodosin 62 CD# monoclonal antibody 62 VEGF receptor 62 atrasentan 62 Aflibercept 62 Lixivaptan 62 P#X# 62 alefacept 62 Curaxin CBLC# 62 IgG1 antibody 62 APOPTONE 62 RhuDex ® 62 Bruton tyrosine kinase Btk 62 HCD# [002] 62 virus HCV protease inhibitor 61 immune modulator 61 Muraglitazar 61 gonadotropin releasing hormone GnRH 61 Plicera 61 bispecific antibody 61 RAV# 61 oral FTY# 61 trodusquemine 61 Smac mimetics 61 TACI Ig 61 Traficet EN 61 histone deacetylase HDAC inhibitor 61 oxysterols 61 OHR/AVR# 61 raloxifene Evista 61 olaparib 61 Aplidin 61 ORMD 61 pharmacodynamic profile 61 lapatinib Tykerb 61 Archexin 61 MAGE A3 ASCI 61 direct thrombin inhibitors 61 Panzem 61 macrolide antibiotics 61 Capesaris 61 antisense drug 61 CIMZIA ™ 61 naturally occurring molecule 61 cytostatic 61 vivo potency 61 2DG 61 peripherally acting 61 sitaxsentan 61 delipidation 61 Talabostat 61 molecularly targeted 61 retaspimycin 61 small molecule activators 61 mGluR4 61 mTOR inhibitor 61 Angiotensin Converting Enzyme 61 teplizumab 61 antisense inhibition 61 TriRima 61 tarenflurbil 61 SERCA2a 61 Quinamed 61 Ambrisentan 61 vidofludimus 61 HuMax CD4 61 anti amnesic 61 Everolimus 61 prodrug 61 Tarvacin TM 61 PDGF receptor 61 non nucleoside 61 EXPAREL TM 61 signal transduction inhibitor 61 vivo validation 61 Cyclosert 61 Spiegelmer 61 phase IIa 61 Pathway Inhibitor 61 GHRH 61 MLN# 61 Tumour Vascular Disrupting Agent 61 vascular disrupting agents 61 neurokinin 1 61 antithrombotic agents 61 anti CD3 61 diagnostic biomarker 61 maximally tolerated dose 61 Factor Xa 61 erlotinib Tarceva ® 61 ZK EPO 61 humanized monoclonal antibody 61 #beta HSD1 61 preclinical efficacy 61 Ophena TM 61 exon skipping 61 Diamyd ® 61 selective androgen receptor modulator 61 investigational hepatitis C 61 PEGPH# 61 Monoclonal antibodies 61 GLP toxicology studies 61 Laquinimod 61 Squalamine 61 Abiraterone acetate 61 busulfan 61 AMD# [003] 61 XYOTAX TM 61 TNFa 61 Tumor Necrosis Factor 61 angiotensin receptor 61 Deforolimus 61 PI3K/mTOR 61 Vidofludimus 61 PARI Pharma GmbH 61 Pimavanserin 61 PRX# 61 Tarvacin Anti Viral 61 receptor modulators 61 drug conjugate 61 novel VDA molecule 61 predictive biomarkers 61 peptide antigens 61 Olaparib 61 Daclizumab 61 HGS ETR1 mapatumumab 61 JAK inhibitor 61 phase IIb clinical 61 Vascugel 61 Phase 2a trial 61 TG# [003] 61 Maraviroc 61 phase IIb study 61 muscarinic 61 MT#/MEDI-# 61 TRC# 61 TMC# [002] 61 tafamidis 61 administered intranasally 61 regorafenib 61 interferon beta therapy 61 GSK# [002] 61 luteinizing hormone releasing 61 REG1 61 hypoxia inducible factor 61 PROCHYMAL 61 alkylating agent 61 TRO# 61 MTP inhibitor 61 Tesetaxel 61 Naproxcinod 61 solithromycin 61 isoform selective 61 fusion inhibitor 61 Orally administered 61 delafloxacin 61 Aliskiren 61 Imatinib 61 small molecule tyrosine 61 SIRT2 61 Annamycin 61 Protelos 61 mTOR inhibitors 61 serine protease 61 Azacitidine 61 Solulin 61 florbetaben 61 epothilone 61 Tarceva TM 61 ixabepilone 61 systemic RNAi therapeutic 61 ulimorelin 61 OMP #R# 61 visilizumab 61 HSP# inhibitor 61 ganetespib 61 NOX E# 61 generation antisense 61 Trofex 61 Lu AA# 61 adalimumab Humira 61 T#I [002] 61 immunosuppressant drug 61 Bucindolol 61 cMET 61 mGlu2 3 61 TLK# 61 selective orally bioavailable 61 Elocalcitol 61 5 HT2C receptor 60 bortezomib Velcade 60 Pharmacokinetics PK 60 lipid nanoparticle 60 lomitapide 60 novel topoisomerase 60 targeting CD# 60 Liraglutide 60 Microplasmin 60 ATL# [001] 60 omega interferon 60 EGFr 60 idarubicin 60 Raltegravir 60 MEK inhibitors 60 Lubiprostone 60 lipid particles 60 cinacalcet 60 Amrubicin 60 Poly ICLC 60 Angiolix 60 ceftazidime 60 cetuximab Erbitux R 60 histone deacetylase HDAC 60 Onconase 60 ToGA 60 OXi# 60 nicotinic alpha 7 60 Copegus ribavirin 60 Anacetrapib 60 MDV# 60 BiTE R 60 Ridaforolimus 60 receptor inhibitor 60 immunomodulatory therapy 60 somatostatin analogue 60 antifibrotic 60 Tasimelteon 60 A3 adenosine receptor 60 alvespimycin 60 peroxisome proliferator activated 60 immune modulation 60 Intravail ® 60 selectively binds 60 JAK inhibitors 60 prescribed proton pump 60 nucleotide analog 60 FGFR 60 potent antiproliferative 60 CXB# 60 JAK1 60 Hypoxia Inducible Factor 60 vorinostat 60 Phase #b/#a trial 60 tanespimycin 60 PLX cells 60 Mirapexin 60 optimal dosing regimens 60 Phase #b/#a clinical 60 mecamylamine 60 GRN#L 60 Vernakalant 60 CoFactor 60 NP2 Enkephalin 60 nicotinic receptor 60 Omacetaxine 60 dihydrofolate reductase 60 MKC# MKC# PP 60 Radezolid 60 DFMO 60 JAK3 inhibitor 60 Piperacillin 60 PROfusion 60 Olmesartan 60 XmAb 60 renin inhibitor 60 adenosine A2A 60 nucleoside analogues 60 midstage trials 60 IFN alpha 60 kinase inhibitor 60 Nanobodies ® 60 Tanespimycin 60 lipid particle 60 Anavex #-# 60 ANAVEX #-# [003] 60 5HT 60 Atrasentan 60 SCD1 60 targeted antifolate 60 CaPre TM 60 Darusentan 60 atherosclerosis regression 60 insulin sensitizing 60 Enkephalin 60 goserelin 60 PHX# 60 orally inhaled migraine 60 chemopreventive agent 60 histone deacetylase 60 AKT inhibitor 60 tubulin inhibitor 60 TTR gene 60 DPP4 60 radiolabeled monoclonal antibody 60 immune modulatory 60 davunetide intranasal AL 60 Enhanze Technology 60 eniluracil 60 humanized monoclonal antibodies 60 neuroprotective properties 60 CRAC channel 60 synthetic retinoid 60 phase IIb trial 60 depsipeptide 60 aripiprazole Abilify 60 anticoagulant reversing agent 60 p# inhibitor 60 BCR ABL inhibitors 60 thrombin receptor 60 potent inhibitor 60 forodesine 60 ALK inhibitors 60 Anthim 60 Thiarabine 60 antidiabetic 60 basal insulin analogue 60 Rasagiline 60 CIMZIA TM 60 RGB # 60 favorable pharmacokinetic profile 60 CORT # 60 mGluR5 antagonists 60 docetaxel Taxotere ® 60 nitric oxide donating prostaglandin 60 selective kinase inhibitor 60 Bezielle 60 CCR9 60 potent topoisomerase II 60 pharmacological chaperone 60 rxRNA 60 ChronVac C R 60 compound AEZS 60 anti angiogenic agent 60 IFN beta 60 paclitaxel poliglumex 60 Zemiva 60 immunomodulator 60 cyclophilin D 60 Rivaroxaban 60 clevidipine 60 Trastuzumab 60 Xanafide 60 small molecule thrombopoietin 60 Janus Kinase 60 KRN# 60 PI3K AKT 60 Stapled Peptide 60 Vicriviroc 60 KSP inhibitor 60 Debio 60 pDCs 60 anti mitotic 60 antitumor effects 60 midstage clinical 60 PEGylated 60 Personalized Immunotherapy 60 erlotinib Tarceva 60 Nexavar ® 60 GAMMAGARD 60 basal bolus regimen 60 LT NS# 60 Galectin 60 R#/MEM 60 calcitonin gene related 60 ALN TTR# 60 CCR2 60 SNT MC# 60 CXCR4 receptor 60 enzyme inhibitor 60 NV1FGF 60 Aclidinium 60 Myocet 60 acyclovir Lauriad R 60 rosuvastatin Crestor 60 JAK#/JAK# 60 crizotinib PF # 60 neurotrophic factor 60 Aeroquin 60 p# MAP kinase 60 Aviptadil 60 rilonacept 60 LymphoStat B TM 60 anticancer therapeutics 60 Epanova 60 ACV1 60 novel prodrug 60 Apixaban 60 EGS# 60 PARP inhibitor 60 immunomodulating 60 IFN α 60 trial evaluating PRX# 60 glucocorticoid receptor 60 Rigel R# 60 INGN 60 Protease inhibitors 60 HGS ETR1 60 ACZ# 60 multicenter Phase II 60 SGS# 60 Maribavir 60 oral Hsp# inhibitor 60 HDACi 60 CCL# 60 Elagolix 60 siRNA therapeutics 60 generation nucleoside analog 60 antisense oligonucleotide 60 AEGR 60 ADAGIO study 60 PRTX 60 immunotherapeutic vaccine 60 reversible inhibitor 59 Panzem R 59 ATL# [002] 59 Belimumab 59 albiglutide 59 Panzem NCD 59 mineralocorticoid receptor 59 IRX 2 59 elotuzumab 59 tasocitinib 59 human IgG1 monoclonal 59 SGLT 59 peptide hormone 59 Atripla combines 59 AEZS 59 Solorel TM 59 Abiraterone 59 davalintide 59 LHRH receptor positive 59 Seliciclib 59 Randomized Phase 59 PS# [001] 59 Zalypsis 59 FGFR1 59 CytoFabTM 59 paclitaxel Taxol 59 LSI #P 59 Ceflatonin R 59 Vidaza azacitidine 59 prodrugs 59 biologic therapy 59 antiplatelet agent 59 oral dihydropyrimidine dehydrogenase DPD 59 Curaxin 59 Teriflunomide 59 imatinib Gleevec ® 59 oral antiviral 59 vemurafenib 59 AZILECT ® 59 endothelin receptor 59 Sudhir Agrawal D.Phil 59 soluble receptor 59 Telmisartan 59 torezolid 59 Bevirimat 59 ibandronate 59 selectively inhibited 59 pegylated liposomal doxorubicin 59 Resten NG 59 GLP1 59 tezampanel 59 IMiDs ® 59 preclinical compounds 59 TRIOLEX 59 Prodarsan ® 59 Cannabinor 59 thetreatment 59 XL# XL# 59 pegylated interferons 59 camptothecin 59 virus AAV 59 Bavituximab 59 oral salmon calcitonin 59 MORAb 59 THR beta agonist 59 Mg Usa 59 SARMs 59 triphendiol 59 personalized immunotherapy 59 docetaxel Taxotere R 59 Anticalins ® 59 diarrhea predominant irritable 59 huN# DM1 59 sulindac 59 Bryostatin 59 SGLT 2 59 PLX# 59 cancer immunotherapies 59 NXL# 59 recurrent glioblastoma multiforme 59 Factor Receptor 59 Glucagon Like Peptide 59 long acting muscarinic 59 irreversible inhibitor 59 tyrosine kinase inhibitor TKI 59 #I TM# 59 TKM ApoB 59 Pharmacokinetic studies 59 statin simvastatin 59 humanised monoclonal antibody 59 zileuton 59 multikinase inhibitor 59 Ophena 59 Desmoteplase 59 S/GSK# 59 MEK Inhibitor 59 fluticasone furoate 59 TLR agonists 59 Nexavar sorafenib 59 Nanobodies 59 Allovectin 7 59 microtubule inhibitor 59 selective androgen receptor modulators 59 mAbs 59 MET inhibitor 59 AZILECT R 59 PD# [005] 59 Irinotecan 59 milatuzumab 59 engineered RAP peptides 59 Gamunex C 59 Aptivus ® 59 tenofovir Viread 59 intranasal delivery 59 peptidomimetic 59 CD# antibody [001] 59 Bosutinib 59 TAKSTA 59 gastrointestinal stromal tumors GIST 59 NSCLC tumors 59 PI3 kinase 59 Fleximer 59 Amigal 59 Elotuzumab 59 investigational pan BCR 59 Darapladib 59 IMiDs R 59 R roscovitine 59 M2 subunit 59 Tezampanel 59 Linaclotide 59 Bortezomib 59 rNAPc2 59 MetAP2 59 tumor antigen 59 Thiovir 59 sphingosine kinase 59 NS#/#A protease 59 Epidermal Growth Factor Receptor 59 Fx #A 59 tezampanel NGX# 59 demonstrated antitumor activity 59 Chemophase 59 Fulvestrant 59 receptor antagonists 59 Novolimus 59 Phase #/#a 59 immunomodulatory 59 paricalcitol 59 opioid receptor antagonist 59 CD3 monoclonal antibody 59 trastuzumab DM1 59 Ocrelizumab 59 cathepsins 59 enzastaurin 59 hypoxic tumors 59 muraglitazar 59 Vaprisol 59 pharmacokinetic PK profile 59 TRV# [001] 59 EZN 59 oncolytic 59 Arikace 59 tipranavir 59 Cand5 59 targeting PCSK9 59 ALN VSP 59 mRNA antagonists 59 octreotide acetate 59 receptor blockers 59 ALN HPN 59 velafermin 59 chemically modified siRNA 59 small molecule activator 59 Factor NGF 59 SCIB1 59 anti arrhythmic drug 59 Avanafil 59 IL# PE#QQR 59 cognitive enhancer 59 multicenter Phase III 59 cetuximab Erbitux 59 SUTENT ® 59 eIF 4E 59 Pradefovir 59 androgen receptor AR 59 ARIKACE ™ 59 TELINTRA 59 NVA# 59 Alexza Staccato 59 Multimeric 59 dacetuzumab 59 rHuPH# 59 subcutaneous formulation 59 MGd 59 DiLA2 59 DACH platinum 59 partial agonists 59 CYC# 59 PROSTVAC TM 59 TRX1 59 rFIXFc 59 nanoviricides 59 darapladib 59 S#P# 59 Zysolin TM 59 GRNCM1 59 PET tracers 59 BMS # 59 mapatumumab 59 peptibody 59 accumulate preferentially 59 epigenetic therapies 59 GALNS 59 humanized monoclonal 59 Menerba 59 Phase IIb clinical trials 59 BENICAR HCT 59 seliciclib 59 Phase IIa trial 59 DB# [003] 59 nalbuphine ER 59 K ras mutations 59 beta adrenergic 59 motesanib 59 investigational therapies 59 ADVANCE PD 59 taxane chemotherapy 59 MEK inhibitor RDEA# 59 Aurora kinase 59 DGAT 59 nucleoside analogue 59 refractory prostate cancer 59 mediated inhibition 59 plasmid DNA vaccine 59 ERK pathway 59 angiotensin II receptor 59 Fenretinide 59 GV# [001] 59 midstage studies 59 LNPs 59 Pazopanib 59 LymphoStat B belimumab 59 plasma kallikrein inhibitor 59 TNF receptors 59 RezularTM 59 ZFP TF 59 endostatin 59 Factor Xa inhibitor 59 Locteron 59 Vicinium TM 59 tranilast 59 metastatic castration resistant 59 PF # [001] 59 druggable targets 59 nanopharmaceutical 59 thiazolidinediones TZDs 59 receptor antagonist 59 beta1 59 viral kinetics 59 Darunavir 59 Imetelstat 59 Ozarelix 59 pharmacodynamic effects 59 DPP4 inhibitor 59 glucagon receptor 59 JAK3 59 ancrod 59 cardioprotective effects 59 AIR# [001] 59 chemotherapeutic regimen 59 DP b# 59 Relivar 59 kinase inhibition 59 MKC# MT 59 Serdolect ® 59 CD# CEA 59 adipiplon 59 vitamin D analogs 59 TH# [003] 59 Technosphere Insulin 59 ANG# 59 ARIKACE 59 CINQUIL 59 aurora kinase 59 selective inhibitors 58 Ampakine 58 Serdaxin 58 nitazoxanide 58 parathyroid hormone PTH 58 LAF# 58 urocortin 2 58 Pemetrexed 58 prostanoid 58 antifolates 58 Adalimumab 58 HepDirect prodrug 58 optimized siRNA 58 PNP inhibitor 58 lentiviral vector 58 next generation URAT1 58 Spiegelmer ® 58 PLK1 SNALP 58 amylin 58 Teriparatide 58 Icatibant 58 alpha TNF